Life sciences · Preprint
arXiv · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Modern computational methods can now propose candidate molecules, materials, and other scientific designs at an unprecedented scale, creating a validation congestion where candidates are abundant, but experimental capacity to physically evaluate them remains scarce. Discovering novel scientific designs has therefore become increasingly dependent on curation: selecting a small set of promising designs for slow and costly experiments. Existing curation methods typically rely on data-driven regression models that predict absolute scores, but training these models requires substantial experimental data to begin with. Yet, useful curation signals do not have to take the form of absolute measurements, as scientific design discovery is often comparative in nature. Here, we propose that curation can instead be primarily driven by expert pairwise rankings, which are substantially easier to gather. The expertise can come from computational tools or human input of multiple levels of fidelity, ranging from empirical rules of thumb to agentic workflows and experienced scientists. We introduce PRISMS, a framework that uses pairwise rankings from one or more experts, potentially spanning multiple levels of expertise, to identify the most promising candidates without relying on data-hungry regressors. When experts differ in fidelity and cost, PRISMS escalates pairwise queries from lower- to higher-fidelity rankers based on a Fisher-information criterion. In iterative screening that selects designs from fixed drug discovery libraries, PRISMS achieves 50% top-10 discovery recall in ~42% fewer rounds than regression-only active learning, and in ~15% fewer rounds than the ranking-based method with no selective escalation. In optimization that generates new designs without restriction to a predefined library, PRISMS achieves ~18.8% higher hypervolume than the Bayesian optimization baseline.